Table 1.
Outcomes | COVID-19 perioda, mean (SD)b | Comparison period | ||||||
|
|
Previous 29 weeksc | Same 29 weeks of previous yeard | |||||
|
Mean (SD)b | COVID-19 period change (%)e,f | P value | Mean (SD)b | COVID-19 period change (%)e | P value | ||
Opioid overdose–related EMSg runs | 25.6 (5.6) | 18.6 (6.6) | 37.4 | <.001 | 20.6 (6.5) | 24.3 | .003 | |
Naloxone administrations | 22.3 (6.2) | 14.1 (6.0) | 57.8 | <.001 | 17.2 (6.9) | 29.7 | .006 | |
Multiple naloxone administrations | 5.0 (1.9) | 2.7 (1.9) | 84.8 | <.001 | 3.3 (1.8) | 51.5 | <.001 |
aMarch 10 to September 30, 2020.
bWeekly mean and SD of outcome during period.
cSeptember 2, 2019, to March 9, 2020.
dMarch 13 to October 5, 2019.
e(COVID-19 period mean – comparison period mean) / comparison period mean.
fThe percentage changes shown may not correspond exactly to the values shown due to rounding.
gEMS: emergency medical services.